SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers
- Conditions
- Mild Cognitive ImpairmentAlzheimer Disease
- Interventions
- Behavioral: A Program of SUPPORT-D (dementia)
- Registration Number
- NCT05501119
- Lead Sponsor
- Medical University of South Carolina
- Brief Summary
The purpose of this research is pilot test a nurse led intervention previously used in patients with pulmonary fibrosis and their caregivers in a new population (persons living with Mild Cognitive Impairment or Alzheimer's disease and their caregivers. The researchers hypothesize improving advanced care planning in this population will result in enhanced quality of life over illness trajectory and improve safety for community dwelling PWD/CG dyads. Findings from this study will inform additional necessary adaptations required prior to conducting larger scale powered randomized control trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 58
The participants in this study include persons with Alzheimer's disease (PWD) and their caregivers (CG.
- Persons with Alzheimer's Disease (investigators anticipate cognitive impairment within this group)
- 18 years old or older
- Diagnosis of Alzheimer's Disease or suspected Alzheimer's disease (FAST score < 4)
- Able to read and speak English (intervention in English)
Caregivers (CG)
- > 18 years old
- Non-paid (eliminates professional caregivers)
- Provides care to someone living with Alzheimer's Disease or suspected Alzheimer's disease (self-report)
- Able to read and speak English (written materials in English)
- No diagnosis of cognitive impairment
- Inability or unwillingness to provide informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description SUPPORT-D Group A Program of SUPPORT-D (dementia) -
- Primary Outcome Measures
Name Time Method Change in Alzheimer's Disease Knowledge Scale (ADKS) Score baseline, at study completion, an average of 8 weeks 30 items (T/F) summed total of correct items higher score indicates higher knowledge (scores range from 0-30)
Acceptability of Intervention Measure (AIM) Score at study completion, an average of 8 weeks 4 items (5 point Likert scale) average score across items higher score indicates more acceptability of intervention (raw score ranges from 4-20)
Feasibility Score at study completion, an average of 8 weeks 4 items (5 point Likert scale) average score across items higher score indicates greater feasibility of intervention (raw scores range from 4-20)
Change Zarit Caregiver Burden Score baseline, at study completion, an average of 8 weeks 12 items (5 point Likert scale (0-4)) summed score with higher scores indicating greater caregiver distress (raw scores range from 0-48)
Change in Perceived Stress Scale Score baseline and at study completion, an average of 8 weeks 10 items (4 point Likert scale ranging from 0-4) summed score across items with higher scores indicate greater levels of stress (scores range from 0-40)
Change in Quality of Life-Alzheimer's Disease (QoL-AD) Score baseline and at study completion, an average of 8 weeks 13 items (4 point Likert scale ranging from 1-4) summed score across items with higher scores indicating better quality of life (scores range from 13-52)
Change in Self-efficacy for Caregiving Score baseline and at study completion, an average of 8 weeks 8 items rated from 1-10 mean score across items with higher scores indicating higher self-efficacy (raw scores range from 8-80)
Change in Safety Assessment Scale Score baseline and at study completion, an average of 8 weeks 16 items with response options ranging from 0 to 4. The minimum score is 0, indicating no safety concerns, while the maximum score is 64, indicating significant safety risks.
Appropriateness of Intervention Score at study completion, an average of 8 weeks 4 items (5 point Likert scale) average score across items higher score indicates greater appropriateness of intervention (scores range from 4-20)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States